Skip to Main Content

Clinical Medicine: Risk Reduction

Risk Reduction

Cardiac Disease

The Heart Outcomes Prevention Evaluation Study Investigators. Effects of an Angiotensin-Converting-Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients. N Engl J Med 2000; 342:145-53.

CCS Guideline Programs:

Diabetes

The Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of Intensive Glucose Lowering in Type 2 Diabetes. N Engl J Med 2008; 358; 2545-59.

The ADVANCE Collaborative Group. Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes. N Engl J Med 2008; 358:2560-72.

Dyslipidemia

Canadian dyslipidemia guidelines

CCS Guideline Programs - Dyslipidemia

Hypertension

CHEP Guidelines

Effects of an Angiotensin-Converting-Enzyme Inhibitor, Rampril, On Cardiovascular Events in High-Risk Patients. HOPE investigators. NEJM. 342(3): 145-53

Apps!

CCS Guidelines Apps

Atrial Fibrillation Guidelines

iPhone, iPad and iPhone Touch

Driving Guidelines

iPhone, iPad and iPhone Touch

Lipid Guidelines

iPhone, iPad and iPhone Touch

CHEP Canadian Hypertension Recommendations App via iTunes

Last Updated: Mar 11, 2024 4:11 PM
URL: https://libguides.usask.ca/medicine
Print Page

Subjects: Health Sciences, Medicine